MEDICAMENTOS EXCLUSIVOS SIROLIMUS (RAPAMUNE), AXITINIB (INLYTA), SUNITINIB (SUTENT), CRIZOTINIB (XALKORI), BOSUTINIB (BOSULIF), PALBOCICLIB (IBRANCE), CEFTAZIDIMA/AVIBAZTAM (ZAVICEFTA), CEFTAROLINA (ZINFORO), ISAVUCONAZOL (CRESEMBA) Y VORICONAZOL SUSP. (VFEND).
Tender information
TED EUMadrid, Spain
- Type
- 29
- Procedure
- neg-wo-call
- Ref. number
- 34961-2025
- Estimated value
- 153,562 EUR
- CPV
- 33600000
MEDICAMENTOS EXCLUSIVOS SIROLIMUS (RAPAMUNE), AXITINIB (INLYTA), SUNITINIB (SUTENT), CRIZOTINIB (XALKORI), BOSUTINIB (BOSULIF), PALBOCICLIB (IBRANCE), CEFTAZIDIMA/AVIBAZTAM (ZAVICEFTA), CEFTAROLINA (ZINFORO), ISAVUCONAZO…